Renovaro Biosciences ( (RENB) ) has provided an announcement.
On February 4, 2025, GEDi Cube B.V., a subsidiary of Renovaro Cube Intl. Ltd. and ultimately Renovaro Inc., amended and restated its employment agreement with Maurice van Tilburg, its CEO. Under the new agreement, van Tilburg will receive a monthly salary and is eligible for an annual bonus, share options, and a pension plan, highlighting the company’s commitment to competitive executive compensation.
More about Renovaro Biosciences
Renovaro Biosciences operates in the biosciences industry with a focus on innovative solutions, and its subsidiary GEDi Cube B.V. is involved in employment agreements and management of senior executive roles.
YTD Price Performance: -8.13%
Average Trading Volume: 1,178,964
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $111.3M
See more data about RENB stock on TipRanks’ Stock Analysis page.